| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
group | 0.100 | None | 1.000 | 24 | 0 | 1998 | 2020 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
group | 0.100 | None | 0.923 | 13 | 0 | 2000 | 2019 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
group | 0.100 | None | 0.923 | 13 | 1 | 2002 | 2019 | ||||||||
|
interferon gamma | 0.288 | 0.962 | 0.47 |
|
group | 0.020 | None | 0.500 | 2 | 0 | 2011 | 2018 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
group | 0.080 | None | 1.000 | 8 | 0 | 2016 | 2019 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
C-reactive protein | 0.299 | 0.962 | 3.7E-03 |
|
group | 0.400 | None | 0.955 | 265 | 1 | 2000 | 2020 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
group | 0.080 | None | 1.000 | 8 | 1 | 2012 | 2019 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
group | 0.100 | None | 0.941 | 17 | 2 | 2003 | 2019 | ||||||||
|
C-X-C motif chemokine ligand 8 | 0.310 | 0.962 | 2.7E-04 |
|
group | 0.060 | None | 1.000 | 6 | 0 | 2004 | 2019 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2018 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
group | 0.400 | None | 0.889 | 18 | 2 | 2004 | 2019 | ||||||||
|
albumin | 0.317 | 0.962 | 0.64 |
|
group | 0.400 | None | 0.965 | 57 | 1 | 1993 | 2020 | ||||||||
|
insulin like growth factor 1 | 0.318 | 0.885 | 0.27 |
|
group | 0.100 | None | 1.000 | 30 | 0 | 1999 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | 0.319 | 0.885 | 1.00 |
|
group | 0.080 | None | 1.000 | 8 | 0 | 2016 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | 0.320 | 0.885 | 1.4E-06 |
|
group | 0.100 | None | 1.000 | 10 | 1 | 2006 | 2019 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 2006 | 2020 | ||||||||
|
toll like receptor 4 | 0.321 | 0.962 | 4.6E-09 |
|
group | 0.100 | None | 0.909 | 22 | 2 | 2005 | 2019 | ||||||||
|
C-C motif chemokine ligand 2 | 0.321 | 0.962 | 0.61 |
|
group | 0.400 | None | 0.952 | 21 | 0 | 2003 | 2020 | ||||||||
|
single-strand-selective monofunctional uracil-DNA glycosylase 1 | 0.322 | 0.923 | 4.5E-04 |
|
group | 0.080 | None | 1.000 | 8 | 0 | 2017 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta | 0.322 | 0.885 | 1.00 |
|
group | 0.080 | None | 1.000 | 8 | 0 | 2016 | 2019 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
group | 0.100 | None | 0.862 | 29 | 3 | 2003 | 2019 | ||||||||
|
interleukin 17A | 0.324 | 0.923 | 4.3E-02 |
|
group | 0.040 | None | 1.000 | 4 | 0 | 2013 | 2018 | ||||||||
|
actin beta | 0.325 | 0.923 | 0.99 |
|
group | 0.080 | None | 1.000 | 8 | 0 | 2006 | 2020 |